Meet the 25 Year-Old Behind L.A.'s Plan to Test Every Resident for COVID-19

Rachel Uranga

Rachel Uranga is dot.LA's Managing Editor, News. She is a former Mexico-based market correspondent at Reuters and has worked for several Southern California news outlets, including the Los Angeles Business Journal and the Los Angeles Daily News. She has covered everything from IPOs to immigration. Uranga is a graduate of the Columbia School of Journalism and California State University Northridge. A Los Angeles native, she lives with her husband, son and their felines.

Meet the 25 Year-Old Behind L.A.'s Plan to Test Every Resident for COVID-19

Fred Turner, the 25-year-old founder of Curative Inc., is the man behind L.A.'s push to bring universal testing to the region. But, he has bigger plans.

Turner, an Oxford dropout, just landed a deal with the Air Force to test military worldwide and he's now eyeing national expansion for his startup. By the end of this month, the company he started months ago is expected to pump out more than a million test kits a week.

"We are a strange company because our goal is to essentially put ourselves out of business," Turner said.


Turner, who was named UK Young Engineer of the Year at age 17 when he built a DNA machine from his bedroom to figure out why his brother had red hair and he had brown hair, turned his focus to coronavirus in January. He upended his life as head of Shield Bio, which sought to eliminate sepsis, and moved to Southern California after a local venture capitalist connected him with a lab that he could build out for COVID-19 testing.

Curative Inc. was born.

Curative, Inc. Founder Fred Turner is the man behind L.A.'s push to bring universal testing to the region.

For weeks he lived in hotels as he created what has become the backbone of testing in America's second largest city. The company, one of the few saliva-based tests that have gotten emergency approvals from the FDA, has a 10% false negative rate, according to their own non-peer reviewed studies. Turner argues the rate is better than most of the nasal swab testing out there and oral tests, which can be self-administered, are the only way the country can reopen quickly.

He is now operating two labs, one in San Dimas another in Washington D.C., with plans for several more across the nation. Meanwhile, the rest of the country is watching to see if Los Angeles' promise of universal testing meets the expectations with some already complaining about the difficulty of securing an appointment.

dot.LA: Curative is responsible for 95% of Los Angeles COVID-19 tests. Can you meet the demand for universal testing?

Curative, Inc. Founder Fred Turner: We will be able to fulfill demand. There's more infrastructure that needs to be put in place. With the collection site, the mayor's office has been working hard to scale those up and make sure that the collection site infrastructure is in place. On the lab side, we definitely have enough capacity to serve the area.

In (the San Dimas) lab we have capacity for about 20,000 per day. We're going to be scaling this lab up to 30,000 over the next week or so, eventually, probably slightly more than that.

Ultimately, the goal is to do as many tests as we need to reopen the country and I think we've had many different estimates of how many that might be. I've heard estimates (that it will take) as high as five million tests a day to reopen, but the current supply chain is nowhere near going to be able to keep up with that. The next goal we are shooting for is a million tests a week by about mid-May, end of May.

If we're testing more people will that strain the turnaround time? Right now, I understand it's about 24 to 72 hours. Can you take it down to several hours or even minutes?

We are always aiming to push it down. I think it can be pushed under 24 hours, but we tend to focus more on scaling it up at that point. I think 24 hours is around optimal as you bring on more capacity. We're obviously being careful to match the capacity coming into the lab against the turnaround.

Curative is one of the few companies that the FDA has provided emergency approval for use of a saliva test. Do you think this is the answer to universal testing nationally?

Oral fluids is the technical term, which is slightly different from saliva. Our protocol involves having the person cough first, which releases virus from the upper and lower respiratory tract. Some of that is then caught in the saliva, and also viruses in the saliva. The idea is you're effectively sampling multiple sites at once, which we think gives a slight increase in the sensitivity of the testing.

Self-collected sampling has got to be the way forward. There's just no way that we can do a million nasal pharyngeal swabs, or we call them 'brain swabs,' it's just not practical. We don't have the medical staff, and as a country we just can't do that many swabs. And so the way forward is going to be self collection. That's the only thing we can do at scale.

Covid-19 Oral Fluid Test Kit Instructions www.youtube.com

Curative recently secured a contract with the Department of Defense. What's next?

We haven't settled on the exact number, but we will be in a large number of states. That is the plan, building out the infrastructure for this kind of testing. We can take the L.A. model and scale it across the country. We have a version of the drive-thru software that other cities and states can take. We have all the training material. We have a team that fly around the country setting up these drive-thru sites. We have really tried to make a plug-and-play package where cities and states that want to launch drive-thru testing, we have everything they need.

Is Los Angeles a testing ground and a proving ground for national efforts?

Yeah, I think Mayor Garcetti has definitely demonstrated what can be done if the city moves very quickly to build out the infrastructure, I do think the drive-thru testing, walk through testing is going to be an essential component of this.

It's just much faster to get the samples to the lab than shipping it out and then shipping it back again. The infrastructure piece is critical for getting these tests out there and we're working with several other states now on building out a similar infrastructure. Some of them have existing programs that we would be plugging into and expanding, and some of them are looking to roll out their own similar programs. You can test a lot more people with the oral tests with far fewer staff.

What are the challenges with the supply chain in terms of making your tests more widely available?

We need more plastic, more robots, more people. Most of the components that go into these tests are just already maxed out in their production capacity. And so we've been throwing online a bunch of internal production, such as injection molding to make our swab kit tubes, as well as bringing on other sources of similar materials that are not being used for COVID-19 testing and validating them for COVID. So for the swabs, for example, we use a swab type that is usually used for testing clean rooms. It works just as well for COVID testing, but nobody else is using it for that purpose.

We don't want to be competing with other people, stopping them from getting access to resources. We want to bring on new supply so it's not a zero- sum game, and the total amount of tests will increase. But, I think distribution is going to be a bigger bottleneck over the next month. Los Angeles has done a fantastic job in building out infrastructure and collection. That needs to happen now across the whole country.

What would it take to meet national demand?

It would take a network of multiple labs that we are calling gigalabs that can process 50,000 to 100,000 tests a day across the country and a significant scale up in the production of the physical components that go into the tests. We've been investigating lab sites in a few states, something central like Texas or Colorado.

Are you concerned that you have too high of a false negative rate at 10%?

All COVID tests will have false negative rates. In our studies, we demonstrated that the sensitivity is at least as good if not better than the nasal pharyngeal swab tests. So, there will definitely be false negatives as there will be in every test, but we think the data supports us having a low rate of false negatives. The sensitivity is about 90%.

When you include all patients, the nasal pharyngeal came in at about 79%. A new (non-peer reviewed) Yale study shows a higher sensitivity from saliva and all fluids than the nasal pharyngeal. I don't think we have the evidence to say that we're better yet, but we have the evidence to say that we're at least equivalent. The ease of doing oral tests and the accessibility is obviously significantly better. We're not using PPE. We're not exposing healthcare workers. It's just a much easier test to roll out that people can test themselves.

File:Florida National Guard (49677710741).jpg - Wikimedia Commons upload.wikimedia.org

At one point, Curative was attempting to roll out at-home testing and then had to pull back after FDA warnings. Will you be making home testing kits again?

I can't give a time estimate but we are actively working with the FDA right now. I think their concern is "can people adequately collect the sample, or will they do it wrong, and then get a negative test result," which is incorrect. Our plan is to use telemedicine observation. What we've seen in our clinical studies is that if you give people the chance to do it wrong, they will do it wrong. In fact when you have somebody observing, they read the instructions better and they collect a better sample. We're still working on the pricing and potentially looking at whether there is federal or state reimbursement for some of that testing and the potential of billing insurance.

Tracing technology has been promising. Do you have any plans to tie tests to these applications to testing?

We've had several conversations with contact tracing apps and we continue to work in collaboration with public health departments in their contract tracing efforts. Having the test is obviously one thing, but you have to use the information to actually stem the tide of COVID infection. And so, it is an essential step in working closely with various people.

I do like the app-based models where you obviously want to maintain people's privacy, but having people opt-in to share their location history if they test positive so you can contact nearby people.

What does Curative do once there's a vaccine? Are you obsolete?

The U.S. needs to maintain some kind of spare capacity so that next time we are not having to build all of this during a pandemic. But we are a strange company because our goal is to essentially put ourselves out of business. Ultimately, and I say this to everyone we hire, we don't know how long this will go on for. We want to provide as many tests as needed, but the goal is to end COVID and not be doing COVID testing anymore.

Curative took off in March when you arrived in Los Angeles from Silicon Valley, how has the journey been for you personally?

I don't have very much free time, but it's been a lot of fun to be able to work at this pace and have the support of people like the city, the mayor's office to really just do what is needed to scale this up. When we work with suppliers, and we say we're doing COVID testing, they just move heaven and earth to make things happen. It's been really inspiring to be a part of that push forward.

We are just pushing as hard as we can to scale up as fast as we possibly can and bring on as much testing as we can. The city opening up testing to everybody is kind of a culmination of that. We're making about 50,000 kits a day right now and we want to make that as widely available as we can. I would like to get a little more sleep.

The interview has been edited for clarity and brevity.

Correction: An earlier version of this story stated that Curative's saliva tests have a 10% false positive rate. In actuality, the tests have a 10% false negative rate.

Do you have a story that needs to be told? My DMs are open on Twitter @racheluranga. You can also email me.

From Your Site Articles
Related Articles Around the Web
https://twitter.com/racheluranga
rachel@dot.la
This El Segundo Startup Wants to Manufacture Medicine in Space
Varda

🔦 Spotlight

Happy Friday, Los Angeles.

The next major pharmaceutical factory may not be built in Boston, New Jersey or Switzerland.

It may be orbiting hundreds of miles above Earth.

El Segundo-based Varda Space Industries raised a $251M Series D this week to advance an ambitious idea: manufacturing medicines in microgravity and returning them to patients on Earth.

The round was led by Lux Capital and Natural Capital, with participation from Founders Fund, Khosla Ventures, Caffeinated Capital, General Catalyst, 8090 Industries, Giant Step and Also Capital. It brings Varda’s total funding to $598M and reportedly values the company at $1.6B.

That is a considerable amount of capital for a company whose factories periodically fall out of the sky.

Then again, that is the point.

Varda builds compact spacecraft that serve as laboratories and manufacturing facilities in orbit. Its W-Series capsules carry pharmaceutical materials into microgravity, process them in space and return the results to Earth through the atmosphere at roughly 25 times the speed of sound.

Why travel that far to make medicine?

Without gravity pulling molecules downward, certain active pharmaceutical ingredients can crystallize in structures that are difficult or impossible to reproduce on Earth. Those differences could eventually enable drug formulations with improved stability, effectiveness or delivery methods.

The science is not entirely new. Researchers have studied pharmaceutical crystallization aboard the International Space Station for decades. Varda’s challenge is turning that research into something considerably less glamorous but far more valuable: a dependable commercial process.

In other words, the company does not merely want to prove that medicine can be made in space. It wants pharmaceutical companies to treat orbit as another step in the development and manufacturing pipeline.

That requires solving the less cinematic half of the space economy.

Rockets have made it increasingly routine to send cargo into orbit. Bringing commercially useful materials safely and repeatedly back to Earth remains much harder. Varda is building both sides of that equation, pairing microgravity processing with capsules capable of surviving hypersonic reentry.

Varda

Since launching its first mission in 2023, Varda says it has completed six successful reentry missions and has more than a dozen additional launches and returns planned through 2028. This week, the company also launched two W-Series spacecraft aboard the same rocket for the first time, marking another step toward operating multiple orbital factories at once.

The new funding will help Varda increase that flight cadence, expand its pharmaceutical partnerships and move closer to delivering what it hopes will become the first medicine manufactured in space for use by patients on Earth.

There is also a second business descending through the atmosphere.

Because Varda’s capsules encounter extreme hypersonic conditions during reentry, they double as research platforms for government customers testing heat shields, navigation systems and other defense technologies. That gives the company a near-term source of demand while its longer-term pharmaceutical market develops.

The combination is distinctly Southern Californian: part aerospace company, part biotechnology startup and part defense contractor, all operating from a city where building hardware for space has become almost commonplace.

But Varda’s larger opportunity depends on making the extraordinary feel routine.

A single successful space experiment is scientifically interesting. A repeatable network of orbital factories could become an industry.

With $598M raised, six reentries completed and a growing mission schedule, Varda has moved beyond asking whether manufacturing in space is technically possible. The more important question now is whether it can become economical, reliable and useful enough for pharmaceutical companies to adopt at scale.

For decades, Los Angeles helped build the machines that carried people and satellites into space.

Varda is betting the region’s next aerospace industry will be built around what those machines bring home.

More from this week’s LA startup and venture scene below.

🤝 Venture Deals

    LA Companies

    • Charter Space raised an oversubscribed $5M seed round led by Crystal Venture Partners, with participation from QED, Blank Ventures, Gaingels and Hustle Fund, bringing its total funding to $8M. The startup will use the capital to expand its sales team and develop insurance products for emerging space activities, including lunar missions, space-based nuclear power and in-orbit spacecraft servicing. - learn more

    LA Venture Funds
    • Emerging Ventures participated in OSCP’s undisclosed Series A, led by New Science Ventures and joined by 2050 Capital. The Montréal company will use the funding to scale production, expand its engineering and sales teams and launch next-generation photonic navigation sensors designed to operate when satellite signals are jammed, spoofed or unavailable. - learn more
    • Slauson & Co. participated in Satlyt’s $8M seed round, led by Non Sibi Ventures and joined by TLCOM, Antler, Launch Africa Ventures, Enza Capital and other investors. The Sunnyvale- and Nairobi-based startup will use the funding to expand its teams and develop software that runs AI directly aboard satellites, reducing costly data transmissions and eventually connecting multiple spacecraft into a shared orbital computing network. - learn more
    • StoryHouse Ventures participated in Parakeet Health’s oversubscribed $10M Series A, led by Canvas Ventures and joined by Blank Space Ventures and HMC INQ. The healthcare AI company will use the funding to expand its platform, which automates patient communications and scheduling, while growing across additional medical specialties and enterprise health organizations. - learn more
    • Parker89 participated in Homeward’s $120M Series D, led by Saluda Grade and joined by Citi Ventures, Norwest, LiveOak Ventures and other investors; the Austin proptech company also secured $330M in asset-backed debt. Homeward will use the financing to expand its cash-offer and bridge-lending products, improve its AI-powered underwriting platform and make its home-buying and selling services available nationwide. - learn more
    • BAM Ventures participated in OuterSignal’s $22M Series A, co-led by Long Journey Ventures and Abstract Ventures and joined by Top Shelf Ventures, AME Cloud Ventures and other investors. OuterSignal will use the funding primarily to expand its team and advance its customer-intelligence platform, which helps consumer brands personalize marketing using detailed profiles built from their existing commerce and CRM data. - learn more
    • Navitas Capital participated in EliseAI’s $350M funding round, led by Andreessen Horowitz and Bessemer Venture Partners and joined by Ontario Teachers’ Pension Plan and Sapphire Ventures, valuing the company at $4B. EliseAI will use the capital to expand its AI platform for housing and other essential-service industries, building tools that automate leasing, resident support and property operations across more than 6.5M housing units. - learn more
    • Bonfire Ventures co-led Destro AI’s $8M seed round alongside Base10 Partners, with participation from CoFound Partners. The Brooklyn startup will use the funding to expand deployments of its AI platform, which coordinates robots from different manufacturers across warehouse operations, while growing its engineering and research teams. - learn more
    • TenOneTen Ventures and Wedbush Ventures participated in Meadow AI’s $7M seed round, led by Ulu Ventures and joined by York IE, Flying Fish and Leadout Capital. The Seattle startup will use the funding to expand its AI-powered “digital secret shopper,” which monitors retail and restaurant operations in real time, while growing its engineering, product and sales teams. - learn more
    • Fika Ventures participated in Outmarket’s $34.5M Series B, led by SignalFire and joined by Permanent Capital Ventures, TTV Capital and Dash Fund. Raised just four months after its Series A, the funding will help Outmarket accelerate development of its AI platform, which automates insurance brokerage tasks such as policy reviews, coverage analysis, proposals and certificates. - learn more

    LA Exits

    • HMBradley, now operating as MBI, has been acquired by personal finance platform Monarch as the buyer surpasses $100M in annual recurring revenue and 1M members. HMBradley co-founder Zach Bruhnke will lead the newly formed Monarch Labs, where his team will develop additional financial products and services designed to help Monarch expand beyond tracking money into helping consumers manage it. - learn more
    • Vision Films has been acquired by Legacy Distribution, combining the Los Angeles companies’ film, television, documentary and specialty-content libraries into a single global distribution business. The combined company will retain the Vision Films name, with Legacy CEO Dana Webber taking the helm and Vision Films founder Lise Romanoff transitioning into a consulting role. - learn more
    • Creative agency Zambezi received a majority investment from health and wellness-focused private equity firm Manna Tree, with financial terms undisclosed. Zambezi will continue operating independently under its existing leadership while providing branding, media and production services to Manna Tree’s portfolio companies and pursuing new business across the broader consumer market. - learn more
    • Santa Monica-based Advertise Purple was acquired by AI-powered marketing company ONAR for up to $27.8M, marking the buyer’s largest acquisition to date. The affiliate marketing agency, which generated $17.1M in 2025 revenue, will retain its leadership team while adding its Bloom analytics platform and more than 111M performance records to ONAR’s technology portfolio. - learn more
    • EasyLlama was acquired through a majority recapitalization by private investment firm Inverness Graham, with financial terms undisclosed. The compliance software company, which serves more than 5,500 small and midsize businesses, plans to expand its platform, partner network and training content while pursuing growth through strategic acquisitions. - learn more

      Download the dot.LA App

      Rainmaker Just Raised $100M to Solve the Weather

      🔦 Spotlight

      Hey Los Angeles.

      Last year, we introduced you to an El Segundo startup that had raised $25M to make it rain.

      This year, rain is apparently just the beginning.

      Rainmaker raised a $100M Series B to expand its cloud-seeding technology and pursue a much larger ambition: building the scientific and technical infrastructure to understand, influence and eventually mitigate extreme weather.

      In startup parlance, it is a pivot from “make it rain” to “solve the weather.” Subtle.

      The round included NOA VC, DCVC, Lowercarbon Capital, Dream Ventures and LA-based Upfront Ventures.

      When we covered Rainmaker last year, the company was preparing to expand its drone fleet, atmospheric research and commercial partnerships.

      It now says it has generated more than 145M verified gallons of precipitation during a four-month period. During a summer research program near Homer, Alaska, Rainmaker says one operation produced 19M gallons in three hours.

      Those are eye-catching numbers. The company’s ambitions are considerably larger.

      Rainmaker is working to build what it calls a “Weather Prime,” combining atmospheric science, autonomous aircraft, sensors and predictive software into an infrastructure platform capable of responding to water scarcity and extreme weather.

      The idea is to make cloud seeding cheaper, more measurable and easier to deploy at scale. Rainmaker’s drones deliver specialized particles into carefully selected clouds, while radar and software help determine where to operate and measure how much additional rain or snow may have been produced.

      The new funding will help Rainmaker hire more atmospheric scientists, meteorologists, chemists and engineers while expanding its research and data-collection capabilities. The company also plans to move toward increasingly autonomous operations, allowing more missions to be conducted at a lower cost.

      Rainmaker expects its cost per acre-foot of water to fall below alternatives such as desalination and agricultural fallowing in the Colorado River Basin during the upcoming water season. If that projection holds, cloud seeding could begin looking less like an experimental intervention and more like another piece of water infrastructure.

      That “if” is doing some serious atmospheric lifting.

      Cloud seeding has existed for decades, but measuring its precise effects remains scientifically difficult. A successful operation requires the right type of cloud at the right moment, and proving exactly how much precipitation would have fallen without intervention is no simple task.

      Rainmaker’s next challenge, therefore, is not merely to produce more rain. It must make the results measurable, repeatable and credible enough for governments, farmers and communities to trust.

      That responsibility becomes even more important as the company expands its vision beyond water. Rainmaker describes cloud seeding as the first step toward eventually mitigating hail, heat and other weather-related threats.

      It is a grand ambition, even by startup standards. Most founders promise to disrupt an industry. Rainmaker wants to influence the atmosphere.

      The company’s location makes the mission particularly fitting. El Segundo has become a center for startups tackling physical problems with drones, satellites, factories and defense systems. Rainmaker is applying that same aerospace-minded approach to one of the West’s oldest constraints.

      For Los Angeles, this story is about more than another substantial funding round. Rainmaker has progressed from proposing that cloud-seeding technology could be modernized to claiming it has produced rainfall at a meaningful scale.

      Now, with four times the capital it announced last year, the company must prove that those results can become dependable infrastructure.

      California has never been shy about reshaping nature to support its growth. Rainmaker is betting that the next great water project will not be built across the landscape.

      It will fly into the clouds.

      More from this week’s LA startup and venture scene below.

      🤝 Venture Deals

        LA Companies

        • Hair care brand Arey raised an undisclosed Series A led by Unilever Ventures, with returning investors Greycroft and Female Founders Fund also participating. The company, which develops supplements and topical treatments for graying and aging hair, will use the funding for product development, clinical research, hiring and retail expansion. - learn more
        • Fluxnium raised a $7M seed round led by Congruent Ventures, with participation from Constellation Technology Ventures and Active Impact Investments. The company will use the funding to develop, test and scale its fiber technology for extracting uranium from seawater, aiming to create a secure domestic alternative to conventional uranium mining. - learn more

        LA Venture Funds
        • Alexandria Venture Investments participated in BigHat Biosciences’ $75M Series C, co-led by DFJ Growth and Premji Invest, bringing the AI-driven biotech’s total funding to $223M. BigHat will use the capital to expand its autonomous protein-design platform and advance its AI-designed cancer therapies, including BHB810 and BHB299, toward key clinical milestones. - learn more
        • Alt Capital participated in Trebellar’s $18M Series A, led by Blossom Capital and joined by Haystack, 1Flourish and Bynd Venture Capital. Trebellar will use the funding to expand its engineering and go-to-market teams and enhance its AI platform, which helps enterprises combine fragmented workplace data to make better real estate decisions. - learn more
        • B Capital participated in Precision Neuroscience’s oversubscribed $250M Series D, co-led by Pershing Square, the Ackman Oxman Institute and an undisclosed life sciences fund, bringing the brain-computer interface company’s total funding to $430M. Precision will use the capital to expand clinical trials, advance its Layer 7 brain implant through additional FDA review and build the infrastructure needed for commercialization. - learn more
        • Mantis Venture Capital participated in Pilgrim’s $25M seed round, led by Buckley Ventures, which valued the Redwood City defense-biotech startup at $150M. Pilgrim is developing a portable system that monitors the air for viruses and other biological threats, with additional backing from Anthropic leaders, Coinbase co-founder Fred Ehrsam and other technology investors. - learn more
        • Starshot Capital participated as a returning investor in Mojave Energy Systems’ $19M Series B, led by Fairtree Elevant Ventures with a significant investment from River Bay Investments. The Sunnyvale company will use the funding to expand manufacturing, grow its sales team and develop new products for its energy-efficient commercial heating, cooling and humidity-control platform. - learn more
        • 4th Revolution Capital participated in infiniFi’s $3M-plus funding round, led by Electric Capital and joined by New Form Capital, Generative Ventures, Fasanara Capital and others. The decentralized finance platform will use the capital to launch infiniFi Prime, expand its products through neobanks and consumer finance apps and prepare for its Q4 token generation event. - learn more
        • Riot Ventures participated in American Supercritical’s $8M pre-seed round, led by Silent Ventures and joined by Harpoon, Reveille VC, Hillwood, Mana Ventures, Climate Capital and Alumni Ventures. The Denver startup is developing compact systems that use supercritical carbon dioxide to convert gas-turbine waste heat into additional electricity, potentially helping data centers generate up to 50% more power without using more fuel or water. - learn more
        • M13 led Baselayer’s $35M Series A, with participation from Torch Capital, Picus Ventures, Afore Capital and Socure executive Matt Thompson. The company will use the funding to expand its identity and risk infrastructure beyond businesses to AI agents, helping financial institutions verify who an agent represents, what it is authorized to do and whether it can be trusted. - learn more
        • BAM Ventures participated in Bird&Be’s $13M funding round, which was led by BDC Thrive and BFG Partners and joined by Founder Collective, Rejuvenation Ventures and HSR Ventures. The fertility and wellness brand will use the capital to develop new supplements and at-home diagnostic tests, expand its retail presence and broaden access to evidence-backed reproductive care. - learn more
        • March Capital joined Snorkel AI’s $350M Series E as a new investor, participating in a round co-led by Insight Partners and S32 that valued the company at $3.5B. Snorkel will use the funding to expand its platform for creating the specialized datasets and training environments needed to develop and evaluate advanced AI models and agents. - learn more
        • Clocktower Technology Ventures is among the investors backing Soteris, which has raised more than $8M in seed funding led by Spider Capital. The Y Combinator-backed insurtech company has emerged from stealth with an AI platform that helps property and casualty insurers identify the profitability and expected losses of individual policies, potentially improving margins without changing rates or staffing. - learn more
        • Smash Capital led Firecrawl’s $75M Series B, with participation from Altos Ventures, Nexus Venture Partners, Y Combinator, Freestyle and Offline Ventures. Firecrawl will use the capital to expand Alexandria, its new platform that gives AI agents one place to access the live web, specialized indexes and licensed data while compensating the people and organizations supplying that knowledge. - learn more
        • ND Capital participated in Ramona’s $25M Series A, which was led by ARCH Venture Partners and joined by Stealthpoint, Fall Line Capital, Hamamatsu, Murchison Capital Partners and Overlap Holdings. Ramona will use the funding to expand production and grow its team as it scales a 24-camera microscope that captures entire biological experiments at cellular resolution, generating richer data for drug discovery and AI models. - learn more
        • Chisos Capital participated in Axio BioPharma’s $2.4M pre-seed round alongside Elmstead Partners, the Chemical Angel Network and several angel investors. The Madison-based company will use the funding to deploy its Axio Lattice platform, which connects manufacturing data across pharmaceutical companies and their partners without requiring either side to replace existing systems or relinquish control of its data. - learn more

        LA Exits

        • Zuma has been acquired by real estate technology company Venn for $50M, bringing its AI leasing tools and engineering team into Venn’s platform. The combined company plans to help multifamily operators automate leasing and eventually expand its AI capabilities into collections, renewals and resident support. - learn more
        • GTXN was acquired by digital asset platform Luno for an undisclosed amount, bringing its licensed collection and payout infrastructure into Luno’s operations. GTXN will serve as Luno’s cross-border payments arm, helping enterprise customers move money between developed and emerging markets through a single provider with fewer intermediaries and faster settlement. - learn more
        • Podium Entertainment was acquired by private equity firms Shamrock Capital and Flexpoint Ford for more than $400M, with GoldState Music also taking a minority stake. The audiobook and publishing company, which has built a catalog of roughly 15,000 titles by working with independent authors, will retain its existing management team. - learn more

          Download the dot.LA App

          Impulse Space Just Raised $308M to Build the Roads in Orbit
          Impulse Space

          🔦 Spotlight

          Happy Friday, Los Angeles.

          Space may not have roads, but it still has a transportation problem.

          Rockets have become remarkably good at carrying satellites beyond Earth. Once those satellites reach space, however, getting them from one orbit to another can still be slow, expensive or impossible.

          Redondo Beach-based Impulse Space wants to change that, and investors are giving it considerably more fuel for the journey.

          The company raised a $308M extension to its Series D, bringing the round’s total to $808M. The new financing comes just over three months after Impulse announced the initial $500M raise and pushes its total capital raised above $1.3B.

          Existing investors 137 Ventures, BANNER VC, DFJ Growth, Linse Capital, Lux Capital and Valor Equity Partners participated in the extension. Impulse did not disclose a valuation, but convincing existing backers to commit another $308M so soon after an already substantial round is a strong signal of confidence in both the company and the market it is pursuing.

          Founded by former SpaceX propulsion executive Tom Mueller, Impulse is building vehicles designed to move satellites and payloads after they have already reached space. If rockets are responsible for getting cargo off the ground, Impulse wants to handle what happens after delivery.

          Impulse Space

          Its Mira spacecraft is built for precise maneuvering, payload deployment and proximity operations in orbit. Helios, scheduled for its first flight in 2027, is a high-energy kick stage designed to move payloads from low Earth orbit to destinations such as geostationary orbit in less than a day. The company has also introduced an electric propulsion system called Electra and a rideshare service aimed at making higher-energy orbits more accessible.

          Together, those products represent something larger than a collection of spacecraft. Impulse is attempting to build a transportation network for an economy that increasingly needs one.

          That need is becoming harder to ignore. More satellites are reaching orbit, governments are prioritizing responsive space capabilities and commercial operators want greater flexibility after launch. A satellite that can change position, reach a different orbit or respond quickly to a new mission is significantly more useful than one permanently tied to its original destination.

          The U.S. government is already putting Impulse’s thesis to work. Helios was selected for the U.S. Space Force’s National Security Space Launch Phase 3 Lane 1 program, making it the first upper-stage prime awarded a position in the program. Impulse also received a $28M contract extension to provide two Mira spacecraft for additional Space Systems Command missions.

          The company says its headcount has more than doubled over the past year as it expanded its facilities in Redondo Beach, Mojave, Boulder and Washington, D.C. The new capital will support further hiring, product development and facility growth as Impulse works to serve commercial, civil and defense customers.

          It also recently appointed its first chief financial officer, Adam Townsend, who previously helped guide Vizio through an IPO and its eventual sale to Walmart. The hire is another sign that Impulse is preparing for a more complex chapter, one defined not only by engineering milestones but also by a growing capital base, government contracts and large-scale operations.

          That is where this announcement becomes more interesting than its considerable price tag.

          Impulse has already shown that Mira can operate in space. Now it must prove that it can turn several ambitious vehicles into dependable infrastructure. The difference between a promising spacecraft company and a transportation network is repetition: more missions, more customers and systems that work reliably enough to become part of how the space economy operates.

          An $808M round gives Impulse the resources to pursue that vision. It also raises the expectations attached to it.

          For Southern California, the financing reinforces the region’s role in the new space economy. Los Angeles helped build the original aerospace industry, and a new generation of companies is now developing the vehicles, factories and infrastructure intended to support life beyond the launchpad.

          Impulse Space is tackling what may be the next big bottleneck. Getting to space is only the beginning.

          Someone still has to get you where you are going.

          More from this week’s LA startup and venture scene below.

          🤝 Venture Deals

            LA Venture Funds

            • Riot Ventures co-led EnduroSat’s $205M funding round alongside Atreides Management, with participation from GV, Founders Fund, Lux Capital, the European Innovation Council and other investors. The Bulgarian space company will use the capital to open a high-volume satellite factory in the U.S., build a major European space and defense hub and scale production of its standardized spacecraft. - learn more
            • Upfront Ventures and M13 participated in Ayble Health’s $16M Series A, led by Neon and joined by Unum Ventures, Cleveland Clinic Ventures, DigiTx and Accomplice. The virtual-care company will use the funding to expand its AI-enabled clinic for chronic digestive and autoimmune conditions across national health plans, major employers and benefits platforms, bringing its total capital raised to more than $27M. - learn more
            • Blue Heron Ventures participated in Voxela’s Series A, led by Delight Ventures and joined by SOMPO Growth Partners, Happiness Capital, Archetype Ventures and ALL STAR SAAS FUND, bringing the eldercare technology company’s total funding to approximately $13.2M. Voxela will use the capital to expand hiring and develop new AI capabilities for its VCare platform, which helps care facilities monitor residents, prevent incidents and automate administrative work such as documentation and reporting. - learn more
            • Clocktower Technology Ventures participated in Mainstay’s more than $18M growth round alongside new investors Parker89, Stackpoint, Alpaca VC and FJ Labs, as well as returning backers Khosla Ventures and Era Ventures. Mainstay also acquired AI-powered listing platform Truelist and will use the funding to bring its real estate data, pricing and automation infrastructure to more brokerages, agents and smaller investors. - learn more
            • Amboy Street Ventures participated in Evvy’s $40M Series B, led by Catalio Capital Management and joined by new and returning investors including Rethink Impact, Muse Capital, Labcorp Venture Fund and General Catalyst. Evvy will use the funding to expand its AI-powered women’s health diagnostics and care platform, beginning with fertility, while growing distribution through physicians and strategic partners. - learn more
            • Second Sight Ventures participated in Fin.com’s $20M seed round, led by Expa and Uber co-founder Garrett Camp, with backing from Coinbase Ventures and other investors. The payments infrastructure startup will use the funding to expand its cross-border network through additional acquisitions and plans to acquire a bank within six months. - learn more
            • Clearlake Capital, Mantis Venture Capital and Sound Ventures participated in Factory’s $200M funding round, which valued the AI software development company at $5B and brought its total funding above $400M. Factory will use the capital to accelerate research, product development and global expansion for its platform, which enables enterprises to build, manage and improve software using autonomous AI agents. - learn more
            • Navitas Capital led Scaffold’s $15M seed round, with participation from D.R. Horton, Pulte Homes, Builders FirstSource and other construction-industry investors. The Austin startup will use the funding to expand its engineering team and broaden its AI-powered platform, which connects homebuilders, contractors and suppliers to automate scheduling, purchase orders and other coordination work. - learn more
            • Halogen Ventures led it’s electric’s oversubscribed bridge round, joined by Wisdom Ventures, Future Communities, E8 Angels and other new and returning investors, bringing the curbside EV-charging startup’s total funding to $15M. The financing will support its rapid expansion, including a New York City contract to install hundreds of locally manufactured chargers across all five boroughs over the next three years. - learn more
            • Matter Venture Partners participated in Delos Data’s more than $100M funding round alongside Matrix, Playground Global, Socratic Partners, Capricorn’s Technology Impact Fund and IAG. The Palo Alto startup will use the capital to expand its engineering teams and accelerate development and sales of its Nonstop AI infrastructure, designed to reduce network bottlenecks and improve the speed and efficiency of AI inference. - learn more
            • Mantis Venture Capital and Gold House participated in A Vinyl Bar in Shibuya’s $5.5M pre-seed round alongside SV Angel, BoxGroup, Quiet Capital and other investors. Founded by Spotify’s former head of innovation, the startup is developing playful music apps that let users remix, manipulate and collaboratively create sounds rather than simply stream or generate songs. - learn more

            LA Exits

            • Headspace has agreed to be acquired by AI healthcare company Sword in a deal expected to close by the beginning of Q4 2026; financial terms were not disclosed. The acquisition will combine Headspace’s mental health brand, global consumer base and network of more than 15,000 providers with Sword’s AI-powered clinical platform to offer more personalized and continuous care. - learn more
            • Nasty Gal was acquired by WSG Brands for an undisclosed amount, adding the women’s fashion label to a portfolio that also includes Von Dutch and Allbirds. WSG plans to expand Nasty Gal internationally and into categories such as footwear, beauty, activewear and accessories while growing its direct-to-consumer, wholesale and licensing businesses. - learn more
            • Converse Health was acquired by healthcare AI company Hello Patient for an undisclosed amount, bringing its back-office automation technology into the buyer’s platform. The combination will allow medical practices to use one system for patient communications and administrative work such as referral processing, chart follow-ups, authorization paperwork and medical records. - learn more

              Download the dot.LA App

              RELATEDEDITOR'S PICKS
              Trending